Trump’s desire to remove a drug tariff exemption for generics and biosimilars produced overseas is ill-conceived and truly damaging to these low-margin industries. The Trump administration seems to think that making generics and biosimilars more expensive to the health system and consumers alike is a great idea. On July 21, President Trump posted on social … Continue reading Trump Tariffs on Generics and Biosimilars: Utter Nonsense or Just Plain Stupidity?